Vascular endothelial growth factor inhibits mitogen-induced vascular smooth muscle cell proliferation

Journal of Surgical Research

Volumn 114, Issue 2, 2003, Pages 179-186

  Dorafshar, Amir H ^a   Angle, Niren ^a,c   Bryer Ash, Michael ^a,b   Huang, Danshan ^a,b   Farooq, Michael M ^a   Gelabert, Hugh A ^a   Freischlag, Julie A ^b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Human aortic smooth muscle; Neointimal hyperplasia; Vascular endothelial growth factor

Indexed keywords

BROXURIDINE; DNA; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGENIC AGENT; RETINOBLASTOMA PROTEIN; VASCULOTROPIN;

AORTA; ASSAY; CELL PROTECTION; CELL STIMULATION; CONFERENCE PAPER; CONTROLLED STUDY; DENSITOMETRY; DNA SYNTHESIS; DOSE RESPONSE; ENZYME PHOSPHORYLATION; HUMAN; HUMAN CELL; MITOSIS INHIBITION; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; QUANTITATIVE ANALYSIS; SMOOTH MUSCLE FIBER; STATISTICAL SIGNIFICANCE; VASCULAR SMOOTH MUSCLE; WESTERN BLOTTING;

EID: 0141927143     PISSN: 00224804     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0022-4804(03)00254-3     Document Type: Conference Paper

References (42)

1. Fischman D.L., Leon M.B., Baim D.S., Schatz R.A., Savage M.P., Penn I., Detre K., Veltri L., Ricci D., Nobuyoshi M., Cleman M., Heuser R., Almond D., Teirstein P.S., Fish R.D., Colombo A., Brinker J., Moses J., Shaknovich A., Hirshfeld J., Bailey S., Ellis S., Rake R., Goldberg S. for the STRESS Investigators. A randomized comparison of coronary-stent placement and balloon angioplasty in the treatment of coronary artery disease. N. Engl. J. Med. 331:1994;496.
2. Healy D.A., Zierler R.E., Nicholls S.C. Long-term follow-up and clinical outcome of carotid restenosis. J. Vasc. Surg. 10:1989;662. discussion 668.
3. Clowes A.W., Reidy M.A., Clowes M.M. Kinetics of cellular proliferation after arterial injury. I. Smooth muscle growth in the absence of endothelium. Lab. Invest. 49:1983;327.
4. Clowes A.W., Reidy M.A., Clowes M.M. Mechanisms of stenosis after arterial injury. Lab. Invest. 49:1983;208.
5. Dicorleto P.E., Bowen-Pope D.F. Cultured endothelial cells produce a platelet-derived growth factor-like protein. Proc. Natl. Acad. Sci. USA. 80:1983;1919.
6. Nilsson J., Sjölund M., Palmberg L., Thyberg J., Heldin C.H. Arterial smooth muscle cells in primary culture produce a platelet-derived growth factor-like protein. Proc. Natl. Acad. Sci. USA. 82:1985;4418.
7. Shimokado K., Raines E.W., Madtes D.K., Barrett T.B., Benditt E.P., Ross R. A significant part of macrophage-derived growth factor consists of at least two forms of PDGF. Cell. 43:1985;277.
8. Kaplan D.R., Chao F.C., Stiles C.D., Antoniades H.N., Scher C.D. Platelet α-granules contain a growth factor for fibroblasts. Blood. 53:1979;1043.
9. Uchida K., Sasahara M., Morigami N., Hazama F., Kinoshita M. Expression of platelet-derived growth factor B-chain in neointimal smooth muscle cells of balloon injured rabbit femoral arteries. Atherosclerosis. 124:1996;9.
10. Majesky M.W., Reidy M.A., Bowen-Pope D.F., Hart C.E., Wilcox J.N., Schwartz S.M. PDGF ligand and receptor gene expression during repair of arterial injury. J. Cell Biol. 111:1990;2149.
11. Ueda M., Becker A.E., Kasayuki N., Kojima A., Morita Y., Tanaka S. In situ detection of platelet-derived growth factor-A and -B chain mRNA in human coronary arteries after percutaneous transluminal coronary angioplasty. Am. J. Pathol. 149:1996;831.
12. Jawien A., Bowen-Pope D.F., Lindner V., Schwartz S.M., Clowes A.W. Platelet-derived growth factor promotes smooth muscle migration and intimal thickening in a rat model of balloon angioplasty. J. Clin. Invest. 89:1992;507.
13. Schlessinger J. How receptor tyrosine kinases activate Ras. Trends Biochem. Sci. 18:1993;273.
14. Seger R., Krebs E.G. The MAPK signaling cascade. FASEB J. 9:1995;726.
15. Nevins J.R. Toward an understanding of the functional complexity of the E2F and retinoblastoma families. Cell Growth Differ. 9:1998;585.
16. Ferrara N., Henzel W.J. Pituitary follicular cells secrete a novel heparin-binding growth factor specific for vascular endothelial cells. Biochem. Biophys. Res. Commun. 161:1989;851.
17. Ferrara N. Vascular endothelial growth factor. Eur. J. Cancer. 32A:1996;2413.
18. Risau W. Mechanisms of angiogenesis. Nature. 386:1997;671.
19. de Vries C., Escobedo J.A., Ueno H., Houck K., Ferrara N., Williams L.T. The fms-like tyrosine kinase, a receptor for vascular endothelial growth factor. Science. 255:1992;989.
20. Millauer B., Wizigmann-Voos S., Schnurch H., Martinez R., Moller N.P.H., Risau W., Ulrich A. High affinity VEGF binding and developmental expression suggest Flk-1 as a major regulator of vasculogenesis and angiogenesis. Cell. 72:1993;835.
21. Gerber H.P., Dixit V., Ferrara N. Vascular endothelial growth factor induces expression of the antiapoptotic proteins Bcl-2 and A1 in vascular endothelial cells. J. Biol. Chem. 273:1998;13313.
22. Gerber H.P., McMurtrey A., Kowalski J., Yan M., Keyt B.A., Dixit V., Ferrara N. Vascular endothelial growth factor regulates endothelial cell survival through the phosphatidylinositol 3′-kinase/Akt signal transduction pathway. J. Biol. Chem. 273:1998;30336.
23. Hockel M., Schlenger K., Doctrow S., Kissel T., Vaupel P. Therapeutic angiogenesis. Arch. Surg. 128:1993;423.
24. Isner J.M., Losordo D.W. Therapeutic angiogenesis for heart failure. Nat. Med. 5:1999;491.
25. Zachary I. Signaling mechanisms mediating vascular protective actions of vascular endothelial growth factor. Am. J. Physiol. Cell. Physiol. 280:2001;C1375.
26. Asahara T., Bauters C., Pastore C., Kearney M., Rossow S., Bunting S., Ferrara N., Symes J., Isner J.M. Local delivery of vascular endothelial growth factor accelerates reendothelialization and attenuates intimal hyperplasia in balloon-injured rat carotid artery. Circulation. 91:1995;2793.
27. Asahara T., Chen D., Tsurumi Y., Kearney M., Rossow S., Passeri J., Symes J.F., Isner J.M. Accelerated restitution of endothelial integrity and endothelial dependent function after phVEGF165 gene transfer. Circulation. 94:1996;3291.
28. Van Belle E., Tio F.O., Couffinhal T., Maillard L., Passeri J., Isner J.M. Stent endothelialization time course, impact of local catheter delivery, feasibility of recombinant protein administration, and response to cytokine expedition . Circulation. 95:1997;438.
29. Van Belle E., Tio F.O., Chen D., Maillard L., Kearney M., Isner J.M. Passivation of metallic stents after arterial gene transfer of phVEGF165 inhibits thrombus formation and intimal thickening. J. Am. Coll. Cardiol. 29:1997;1371.
30. Luo Z., Asahara T., Tsurumi Y., Isner J.M., Symes J.F. Reduction of vein graft intimal hyperplasia and preservation of endothelium-dependent relaxation by topical vascular endothelial growth factor. J. Vasc. Surg. 27:1998;167.
31. Guerrin M., Moukadiri H., Chollet P., Moro F., Dutt K., Malecaze F., Plouet J. Vasculotropin/vascular endothelial growth factor is an autocrine growth factor for human retinal pigment epithelial cells cultured in vitro. J. Cell. Physiol. 164:1995;385.
32. Oberg-Welsh C., Sandler S., Andersson A., Welsh M. Effects of vascular endothelial growth factor on pancreatic duct cell replication and the insulin production of fetal islet-like cell clusters in vitro. Mol. Cell. Endocrinol. 126:1997;125.
33. Sondell M., Lundborg G., Kanje M. Vascular endothelial growth factor has neurotrophic activity and stimulates axonal outgrowth, enhancing cell survival and Schwann cell proliferation in the peripheral nervous system. J. Neurosci. 19:1999;5731.
34. Ishida A., Murray J., Saito Y., Kanthou C., Benzakour O., Shibuya M., Wijelath E.S. Expression of vascular endothelial growth factor receptors in smooth muscle cells. J. Cell. Physiol. 188:2001;359.
35. Grosskreutz C., Anand-Apte B., Dupláa C., Quinn T., Terman B.I., Zetter B., D'Amore P.A. Vascular endothelial growth factor-induced migration of vascular smooth muscle cells in vitro. Microvasc. Res. 58:1999;128.
36. Luo Z., Asahara T., Tsurumi Y., Isner J.M., Symes J.F. Reduction of vein graft intimal hyperplasia and preservation of endothelium-dependent relaxation by topical vascular endothelial growth factor. J. Vasc. Surg. 27:1998;167.
37. Lazarous D.F., Shou M., Scheinowitz M., Hodge E., Thirumurti V., Kitsiou A.N., Stiber J.A., Lobo A.D., Hunsberger S., Guetta E., Epstein S.E., Unger E.F. Comparative effects of basic fibroblast growth factor and vascular endothelial growth factor on coronary collateral development and the arterial response to injury. Circulation. 99:1999;1726.
38. Lindner V., Reidy M.A. Expression of VEGF receptors in arteries after endotheilial injury and lack of increased endothelial regrowth in response to VEGF. Arterioscl. Throm. Vasc. Biol. 16:1996;1399.
39. Laitinen M., Zachary I., Breier G., Paikkanen T., Häkkinen T., Luoma J., Abedi H., Risau W., Soma M., Laakso M., Martin J.F., Ylä-Herttuala S. VEGF gene transfer reduces intimal thickening via increased production of nitric oxide in carotid arteries. Human Gene Ther. 8:1997;1737.
40. Taniguchi Y., Morita I., Kubota T., Murota S., Aso T. Human uterine myometrial smooth muscle cell proliferation and vascular endothelial growth-factor production in response to platelet-derived growth factor. J. Endocrinol. 169:2001;79.
41. Hu J.S., Hastings G.A., Cherry S., Gentz R., Ruben S., Coleman T.A. A novel regulatory function of proteolytically cleaved VEGF-2 for vascular endothelial and smooth muscle cells. FASEB. J. 11:1997;498.
42. Muller Y.A., Li B., Christinger H.W., Wells J.A., Cunningham B.C., De Vos A.M. Vascular endothelial growth factor crystal structure and functional mapping of the kinase domain receptor binding site . Proc. Natl. Acad. Sci. USA. 94:1997;7192.